Sobi - Swedish Orphan Biovitrum AB (publ)

Be part of our future and make a difference. Our commitment to patients knows no borders, and as we continue to expand, we are looking for passionate individuals to join us in shaping the future. Be part of our global family and make a difference for people with rare and debilitating diseases. Explore the possibilities – check out our open positions on LinkedIn or visit sobi.com. #Sobi #RareDiseases #CareerOpportunities

Our commitment to the global sustainable development agenda is at the core of our mission: transforming the lives of people living with rare and debilitating diseases. Our sustainability strategy is integrated into our business and focuses on two main priorities: maintaining our commitment to patients and always acting responsibly. By expanding our geographical reach, investing in the development of innovative medicines, and deepening our engagement in haematology, immunology, and specialty care, we are enhancing access to rare disease treatments for patients around the world, step by step. Learn more about our commitments to patients. https://lnkd.in/e6cSjDP4 #Sobi #RareDiseases #Sustainability

Embark on a journey where passion meets purpose! At Sobi, we are not just colleagues; we are a team driven by purpose with a shared commitment to making a meaningful difference for people living with rare and debilitating diseases. Ready to make a real impact and be part of Sobi’s journey? Explore career opportunities with Sobi now. Learn more about us on Linkedin or sobi.com. #Sobi #RareDiseases #Career

From brewing roots to global biopharmaceutical leadership – discover Sobi's legacy. Our history is a story of challenges overcome. From our Swedish origins, we have grown into an international biopharmaceutical leader, present in 30 countries and delivering medicines worldwide. Our rich heritage of collaborative expertise has empowered us to consistently identify and develop innovative medicines. We are dedicated to addressing significant unmet medical needs and transforming the lives of people living with rare and debilitating diseases. Explore our history and learn more about our journey. https://lnkd.in/dwcwATGv #Sobi #RareDiseases

We hope to see you at the #ISTH2024 congress, from 22-26 June in Bangkok, Thailand. We are looking forward to this event - the 32nd International Society on Thrombosis and Haemostasis (ISTH) congress. This year, we are proud to present new data further demonstrating our commitment to advancing haemophilia treatment standards. It is a fantastic opportunity to gather, connect, and learn from global bleeding and clotting disorders experts. Let’s work together to share our knowledge and improve care for people with haemophilia worldwide. #Sobi #RareDiseases #Haemophilia #ISTH2024 #BleedingDisorders

EHA2024 kicks off today! Join us at the European Hematology Association (EHA) hybrid congress, taking place from 13-16 June in Madrid, Spain. Under the EHA theme “Towards prevention, cure, and quality of life for all patients with blood disorders, this congress promises to be an insightful event. Sobi will have a strong presence at EHA with multiple symposia, oral presentations, and posters. Come visit us in the Sobi booth, we are looking forward to seeing you at EHA 2024. Sobi is proudly supporting the educational project ‘Factor Think Tank’, led by well-known experts in haemophilia, aimed at raising awareness about the current challenges in managing the condition. If you are a healthcare professional interested in haemophilia, don’t miss the opportunity to listen to leading experts. Tune in to the Factor Think Tank https://lnkd.in/dYvE4FdJ #Sobi #RareDiseases #BleedingDisorders #EHA2024 #Haemophilia

EULAR 2024 is just around the corner, and we are excited to attend EULAR - European Alliance of Associations for Rheumatology Congress, in Vienna, Austria, from 12-15 June. The EULAR congress will bring together leading experts to present and discuss the latest scientific breakthroughs in clinical, translational, and basic sciences. We look forward to engaging and forward-looking discussions on new advancements, all with the shared goal of improving the lives of patients worldwide. Hope to see you in Vienna! #Sobi #RareDiseases #EULAR2024

June is Pride Month, a time to honour and celebrate the LGBTQ+ community and the ongoing fight for equality and acceptance. At Sobi, our commitment to inclusion doesn't end in June. We strive to be an inclusive employer, creating an equitable environment where all colleagues can be their authentic selves and have opportunities to realise their full potential. We recognise that Diversity, Equity, and Inclusion (DEI) are critical components in building a successful organisation. Join us in celebrating Pride Month and supporting the LGBTQ+ community. Read more about our DEI efforts: https://lnkd.in/g4Gngq5g #Sobi #PrideMonth #LGBTQ #DEI

We are excited to announce that Guido Oelkers, CEO of Sobi, will be speaking at the Jefferies Global Healthcare Conference in New York, USA. He will discuss how Sobi successfully delivers on its strategy with an audience of over 500 public and private healthcare companies, institutional and private equity investors, and venture capitalists. This year’s gathering will bring together 3,000 leading executives to explore near-and long-term investment opportunities and the current trends shaping healthcare in the U.S. and internationally. #Sobi #RareDiseases #JefferiesHealthcare

Join us at ASCO 2024! We look forward to this year’s American Society of Clinical Oncology (ASCO) annual meeting 2024. This event, taking place from 31 May to 4 June in Chicago, USA, is one of the most significant gatherings of oncology professionals. The ASCO meeting brings together experts from around the globe to share the latest research, innovative treatments, and advancements in cancer care. We are looking forward to insightful discussions, impactful collaborations, and the chance to contribute to our shared mission to improve patient outcomes. #Sobi #RareDiseases #ASCO24 #oncology